<?xml version="1.0" encoding="UTF-8"?>
<article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.1" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id>authorea</journal-id>
      <publisher>
        <publisher-name>Authorea</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.22541/au.169155372.27208968/v1</article-id>
      <title-group>
        <article-title>Atopic dermatitis, sleep and COVID-19 pandemic</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">0000-0002-2667-3540</contrib-id>
          <name>
            <surname>Morgan</surname>
            <given-names>Mariana Aparecida Pasa</given-names>
          </name>
          <address>
            <institution>Universidade Federal do Parana Departamento de Pediatria</institution>
          </address>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name>
            <surname>Roth</surname>
            <given-names>Priscila Vernizi</given-names>
          </name>
          <address>
            <institution>Universidade Federal do Parana Departamento de Pediatria</institution>
          </address>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name>
            <surname>Drizlionoks</surname>
            <given-names>Renata</given-names>
          </name>
          <address>
            <institution>Universidade Federal do Parana Departamento de Pediatria</institution>
          </address>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name>
            <surname>Antunes</surname>
            <given-names>Rafaela Cachiolo</given-names>
          </name>
          <address>
            <institution>Universidade Federal do Parana Departamento de Pediatria</institution>
          </address>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name>
            <surname>Crippa</surname>
            <given-names>Ana Chrystina Souza</given-names>
          </name>
          <address>
            <institution>Universidade Federal do Parana Departamento de Pediatria</institution>
          </address>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name>
            <surname>CARVALHO</surname>
            <given-names>VANIA</given-names>
          </name>
          <address>
            <institution>Universidade Federal do Parana Departamento de Pediatria</institution>
          </address>
        </contrib>
      </contrib-group>
      <pub-date date-type="preprint" publication-format="electronic">
        <day>9</day>
        <month>8</month>
        <year>2023</year>
      </pub-date>
      <self-uri xlink:href="https://doi.org/10.22541/au.169155372.27208968/v1">This preprint is available at https://doi.org/10.22541/au.169155372.27208968/v1</self-uri>
      <abstract abstract-type="abstract">
        <p><bold>Background:</bold> Atopic dermatitis (AD) is a chronic inflammatory
skin disease characterized by pruritus, xerosis and eczema, causing
sleep disorders. This study purpose was to examine sleep disorders among
children with AD, correlating with disease severity scores, lifestyle,
and sleep quality, before and during the coronavirus disease 2019
(COVID-19) pandemic. <bold>Methods:</bold> This is a longitudinal,
analytical, prospective, uncontrolled study included 26 patients with AD
aged 5–10 years from the Pediatric Dermatology Clinic at a
tertiary-care hospital. The Sleep Disturbance Scale for Children
Questionnaire and questions about sleep hygiene and lifestyle habits
were were used. The severity of AD was determined by the
Patient-Oriented Eczema Measure (POEM) index. The first evaluation was
presential conducted from October 2019 to March 2020 and the second from
September to December 2020 by telephone interviews. <bold>Results:</bold>
The severity of AD was considered mild in 76.92% patients in both the
evaluations. Sleep disorder was present in 17 (65.38%) patients in the
first evaluation and in 11 (42.30%) in the second ( <italic>p=0.04</italic>). In
the first evaluation, disorders of initiating and maintaining sleep
(DIMS) was more frequent in moderate-to-severe AD than in mild AD
(83.33% vs. 11.11%, <italic>p=0</italic>. <italic>0025</italic>). During the pandemic, six
patients (23.07%) reported improvement in sleep quality.
<bold>Conclusion</bold>: Sleep quality was negatively influenced by the
severity of AD. During the COVID-19 pandemic, there were changes in
lifestyle habits and improvement in sleep quality, despite the absence
of changes in disease severity.</p>
      </abstract>
      <kwd-group kwd-group-type="author-created">
        <kwd>covid-19</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>
